Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Auspex Pharmaceuticals discloses cytochrome P450 CYP11B1 inhibitors

July 25, 2016

Amgen and UCB submit romosozumab BLA for osteoporosis in postmenopausal women

July 22, 2016

Selecta Biosciences announces new gene therapy programs

July 22, 2016

Aegerion to withdraw lomitapide in E.U.

July 21, 2016

EMA grants orphan drug designation to XOMA-358

July 21, 2016

FDA approves expansion of Synjardy indication

July 21, 2016

Zafgen suspends development of beloranib and refocuses on ZGN-1061

July 21, 2016

Eisai and Arena Pharmaceuticals obtain NDA approval for Belviq XR

July 20, 2016

Aeglea updates progress of AEB-1102 clinical program

July 20, 2016

AstraZeneca receives European approval for Qtern

July 20, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...